Report of a Novel Molecular Profile in Malignant Insulinoma
Journal of Clinical Medicine · 06.02.2023 · 12 (4) · 1280
DOI: 10.3390/jcm12041280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.02.2023. Verfasst von Laura Burns und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic neuroendocrine tumors, or pNETs, represent a rare and clinically heterogenous subset of pancreatic neoplasms. One such pNET, the insulinoma, is found to be malignant in just 4% of all insulinomas. Due to the exceedingly uncommon occurrence of these tumors, there is controversy regarding the optimal evidence-based management for these patients. We therefore report on a 70-year-old male patient admitted with 3 months of episodic confusion with concurrent hypoglycemia. The patient was found to have inappropriately elevated endogenous insulin levels during these episodes, and somatostatin-receptor subtype 2 selective imaging revealed a pancreatic mass metastatic to local lymph nodes, spleen, and the liver. Fine needle aspiration of pancreatic and liver lesions confirmed the diagnosis of a low grade pancreatic neuroendocrine tumor. Molecular analysis of tumor tissue revealed a novel mutational profile consistent with pNET. The patient was initiated on octreotide therapy. However, treatment with octreotide alone demonstrated limited efficacy in controlling the patient’s symptoms, prompting consideration of other therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA 02118, USA.
- Boston University School of Medicine, Boston, MA 02118, USA.
- VA Boston Healthcare System, Boston, MA 02130, USA.
- Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Laura Burns, Bita Naimi, Huihong Xu, Horst Christian Weber
Zitieren
APA
Burns, L., Naimi, B., Ronan, M., Xu, H., & Weber, H. C. (2023). Report of a Novel Molecular Profile in Malignant Insulinoma. Journal of Clinical Medicine, 12(4), 1280. https://doi.org/10.3390/jcm12041280
Vancouver
Burns L, Naimi B, Ronan M, Xu H, Weber HC. Report of a Novel Molecular Profile in Malignant Insulinoma. Journal of Clinical Medicine. 2023;12(4):1280. doi:10.3390/jcm12041280
BibTeX
@article{Burns2023,
author = {Burns, Laura and Naimi, Bita and Ronan, Matthew and Xu, Huihong and Weber, Horst Christian},
title = {Report of a Novel Molecular Profile in Malignant Insulinoma},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {1280},
doi = {10.3390/jcm12041280}
}
EUVIMED